AMR COMBINE

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No 853967.

[AMR COMBINE @AMR_Combine]

The COMBINE project is committed to sustaining #AMRresearch efforts!
Explore results from the @AMRAccelerator projects:
https://t.co/S1DTsMauSh

@IMI_ERA4TB
@UNITE4TB

[IMI AMR ACCELERATOR @AMRAccelerator]

We call on government leaders, the private sector & other stakeholders to invest in #antibiotics development and #AMR research. And secure a sustainable future for efforts like the AMR Accelerator.
Read our call to action in @NatRevDrugDisc
https://t.co/cleavCzqmr

@IHIEurope

[AMR COMBINE @AMR_Combine]

One-Stop Resource for the Latest Developments Against AMR!

The ‘Webinar Archive’ page on our website is a comprehensive collection addressing antimicrobial resistance.

👉 Visit today: https://t.co/89LvFaGtz0

[AMR COMBINE @AMR_Combine]

Can’t Attend the Live Webinar on 13th February? No Problem!

👉 Submit your registration now and receive the recording to watch at a time that works best for you: https://t.co/g2IkTVT7fM

[AMR COMBINE @AMR_Combine]

Looking for a Snapshot of our Accelerator Projects?✨

The '𝗣𝗿𝗼𝗷𝗲𝗰𝘁 𝗣𝗼𝗿𝘁𝗳𝗼𝗹𝗶𝗼 𝗣𝗮𝗴𝗲' has it all !
The interactive table showcases detailed view of our accelerator projects aimed at combating AMR.

👉 Check out our Portfolio page now https://t.co/K3KcgwEj0m

[AMR COMBINE @AMR_Combine]

Learn how:
1️⃣ We built AntiMicrobial-KG, a knowledge graph of antibacterial assay data, and used it to train ML models to find antimicrobial compounds.
2️⃣ Our Random Forest model hit 75.9% accuracy and predicted active compounds in EU-OpenScreen and Enamine libraries.

[AMR COMBINE @AMR_Combine]

How Can We Combat Superbugs?

Hear from Nasreen Hassoun Kheir, lead author of a recent PrIMAVeRa perspective article and infectious diseases expert, as she shares her journey and insights in an exclusive interview.

👉 Read the full interview at: https://t.co/hEutFN29YH

[AMR COMBINE @AMR_Combine]

Reserve your spot today for the upcoming webinar on leveraging Machine Learning (ML)–Tool to address the challenges of antibiotic drug discovery amidst rising AMR.

Join us on February 13, 2025, 15:00 - 16:30 CET

👉 Register now to secure your spot: https://t.co/rjHApAa7CP

[IMI AMR ACCELERATOR @AMRAccelerator]

𝗙𝗶𝗻𝗱 𝗢𝘂𝘁 𝗪𝗵𝗮𝘁’𝘀 𝗔𝗵𝗲𝗮𝗱 𝗳𝗼𝗿 𝗬𝗼𝘂 𝗪𝗶𝘁𝗵 𝗨𝘀 𝗶𝗻 𝟮𝟬𝟮𝟱! ✨

Stay tuned with us for:
💻 More & More Webinars
🔬 Projects under AMR Accelerator delivering results
🧰 Updated 'News Page' on website

👉Visit our page at https://t.co/8FVgZvQZni

[AMR COMBINE @AMR_Combine]

Discover links to public webinars, interviews with early career researchers, and many more insights from AMR Accelerator projects in the December issue!

[IMI AMR ACCELERATOR @AMRAccelerator]

Hot off the press! Our latest AMR Accelerator Newsletter is here!
In this issue, the PrIMAVeRa project is under the spotlight.

Stay informed and inspired—our newsletter is packed with insights for #AMRresearch supporters.

👉 Read it now: https://t.co/vqiKR1xV0m
#AMRaccelerator

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

🚨Naming Challenge Alert 🚨

Neisseria gonorrhoeae is resistant to nearly all types of all types of antibiotics used to treat it, but YOU can help us take it down by giving it a name!

Got a fierce or funny name for this menace?
Drop it below👇Winning name takes the glory!

[IMI AMR ACCELERATOR @AMRAccelerator]

Stay in the loop: https://t.co/ceqzwEfBYs

Sign up for our newsletter and get the latest updates, insights, and exclusive content delivered straight to your inbox!

[Uppsala Antibiotic Center @UAC_UU]

This week we learn about the access to #antibiotics in the Nordic Region 🇸🇪 🇩🇰 🇳🇴 🇫🇮, in a conference organized by the @LV_MPA
Impressive comprehensive program exploring key concepts & processes, from R&D to market use.

How do we ensure access in a world with increased #AMR?

[AMR COMBINE @AMR_Combine]

Our consortium member grit42 announced that the grit Scientific Data Management Platform will be released for free!
Platforms like this drive #collaboration and #sustainability of #AMRresearch while promoting #OpenScience and #innovation.

Read more: https://t.co/yhWF4mebJ9

[AMR COMBINE @AMR_Combine]

The fifth COMBINE Annual meeting gathered on October 28-29 in Madrid for an update on the main achievements and an outlook plan to ensure the project’s legacy beyond its lifetime.

[AMR COMBINE @AMR_Combine]

Accessing content from Nature Reviews Drug Discovery requires a subscription. Therefore, we are providing free access to a digital reprint of the article from our website: https://t.co/zrqeyMxUG4

[AMR COMBINE @AMR_Combine]

The COMBINE project is committed to sustaining #AMRresearch efforts!
Explore results from the @AMRAccelerator projects:
https://t.co/S1DTsMauSh

@IMI_ERA4TB
@UNITE4TB

[IMI AMR ACCELERATOR @AMRAccelerator]

We call on government leaders, the private sector & other stakeholders to invest in #antibiotics development and #AMR research. And secure a sustainable future for efforts like the AMR Accelerator.
Read our call to action in @NatRevDrugDisc
https://t.co/cleavCzqmr

@IHIEurope

[AMR COMBINE @AMR_Combine]

The webinar is free for the public, but you need to register!

Secure your spot now:
https://t.co/27MKDNCzXB

[AMR COMBINE @AMR_Combine]

🚨🚨🚨
Join us and @IMI_ERA4TB for a #webinar with Dr. Radu Botgros from @EMA_News on November 6, 15:00 CET!
Learn how to engage w/ the EMA on drug and vaccine development now: https://t.co/27MKDNCzXB

#AntimicrobialResistance #AMR #DrugDevelopment #VaccineResearch #PublicHealth

[AMR COMBINE @AMR_Combine]

🚨🚨🚨
Join us and @IMI_ERA4TB for a #webinar with Dr. Radu Botgros from @EMA_News on November 6, 15:00 CET!
Learn how to engage w/ the EMA on drug and vaccine development now: https://t.co/27MKDNCzXB

#AntimicrobialResistance #AMR #DrugDevelopment #VaccineResearch #PublicHealth

[IMI AMR ACCELERATOR @AMRAccelerator]

#Antibiotic resistance threatens the vision to eradicate #tuberculosis by 2035. @IMI_ERA4TB emphasizes the need to maintain expertise and capability for new treatments for infectious diseases, like #TB. 👇

🔗 https://t.co/oeWYNj64XE

[AMR COMBINE @AMR_Combine]

We are proud that our coordinator, Anders Karlén, received the Pharmacist of the Year 2024 Award from the Swedish Pharmacists Association!

"I am very honored by the award and of having the privilege to work with a very committed team", says Anders.
https://t.co/AMlrxCW5pO

[Centre for Research Ethics & Bioethics @crb_uu]

JUST PUBLISHED: The AMR Accelerator: from individual organizations to efficient antibiotic development partnerships @NatRevDrugDisc 👇https://t.co/3cSOepbzvV

[npj Antimicrobials and Resistance @npjAMR]

Five years in, a reflection on the #AMR Accelerator programme's value, results and key challenges: ensuring the sustainability of assets, infrastructures and expertise🧑‍🔬

#antibioticDevelopmentPartnerships

https://t.co/lT3n17uqAb